Red blood cell polymorphism and susceptibility to Plasmodium vivax.
about
Do advanced glycation end-products play a role in malaria susceptibility?Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory ResponseThe influence of host genetics on erythrocytes and malaria infection: is there therapeutic potential?The utility of genomic data for Plasmodium vivax population surveillanceOnline biomedical resources for malaria-related red cell disordersMalaria Parasites: The Great EscapeAdvances in genetics and genomics: use and limitations in achieving malaria elimination goalsFrom within host dynamics to the epidemiology of infectious disease: Scientific overview and challengesPlasmodium vivax sporozoite challenge in malaria-naïve and semi-immune Colombian volunteersSusceptibility to Plasmodium yoelii Preerythrocytic Infection in BALB/c Substrains Is Determined at the Point of Hepatocyte InvasionGlobal Epidemiology of Plasmodium vivaxHuman vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies.Epidemiology of disappearing Plasmodium vivax malaria: a case study in rural AmazoniaPotential immune mechanisms associated with anemia in Plasmodium vivax malaria: a puzzling questionWhole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strains.Molecular epidemiology of Plasmodium vivax and Plasmodium falciparum malaria among Duffy-positive and Duffy-negative populations in EthiopiaAtypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout micePlasmodium vivax Transmission in Africa.Improvement of culture conditions for long-term in vitro culture of Plasmodium vivax.Is there malaria transmission in urban settings in Colombia?Structurally conserved erythrocyte-binding domain in Plasmodium provides a versatile scaffold for alternate receptor engagement.Consistent prevalence of asymptomatic infections in malaria endemic populations in Colombia over timeThe Legacy of Past Pandemics: Common Human Mutations That Protect against Infectious Disease.Molecular evidence of Plasmodium vivax infection in Duffy negative symptomatic individuals from Dschang, West Cameroon.Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas.Host-parasite interactions that guide red blood cell invasion by malaria parasites.Genome-wide diversity and differentiation in New World populations of the human malaria parasite Plasmodium vivax.Malaria Pathogenesis.Evaluation of Immunoglobulin G Responses to Plasmodium falciparum and Plasmodium vivax in Malian School Children Using Multiplex Bead Assay.Humoral immune responses to a recombinant Plasmodium vivax tryptophan-rich antigen among Plasmodium vivax-infected patients and its localization in the parasite.Blood transcriptional signature of recombinant human erythropoietin administration and implications for antidoping strategies.Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians.The Promise of Systems Biology Approaches for Revealing Host Pathogen Interactions in Malaria.Human migration and the spread of malaria parasites to the New World.A guide to chemokines and their receptors.Micro-epidemiology of mixed-species malaria infections in a rural population living in the Colombian Amazon region.Transfusion Medicine and Molecular Genetic Methods.Cytotoxic CD8 T cells recognize and kill Plasmodium vivax-infected reticulocytesMalaria Vaccines: Recent Advances and New Horizons
P2860
Q24471760-0881D734-4A0C-4FB4-BB78-3DE2C3F73332Q26744960-120A5290-CAE0-46A8-BCC8-2B3D095B548DQ26799240-35DFF2AD-9480-42D1-B53A-2608EBEDB583Q26865002-F9D1029A-24E3-4663-B3A8-B8BC10960DE1Q27024694-A2504B09-3781-4226-B8B9-96EB5F2CDBA9Q28080325-96C034A1-39FA-45D7-A1B1-75993E15F026Q28082023-DB79D09D-5AC6-485E-8311-F89AE8AB77CCQ28087108-4BAC5017-4B3D-4938-9AE9-A705069B3AF1Q28539992-F3E331EB-DA6F-40B5-9AE8-7ABC963E4EAFQ29031063-CC0A380C-12B1-4F1A-AF07-241F2496DC40Q30249044-5AC31974-0494-4858-BF8A-2B9D3CEB7E74Q33798074-1BD7953F-5613-4DF4-A191-648B0BDBDEC3Q34104487-51E645C5-55C8-4F05-921E-A6140C28080AQ34298686-F2506FCB-9992-4960-B8FE-4C739261E3D8Q35054176-5E67D754-BD75-42AC-99E0-79EFD9EF3423Q35122442-0EC8F50F-1D2D-4736-AE02-A7699D8FFF73Q35661830-C270FB34-BBEC-486F-B427-D81CC6E4F2D1Q35847037-187503C7-3BC6-4CD3-B2FD-14C21ED20278Q35914904-17E057B3-8934-40FC-9D23-839400F132FCQ36286450-86006338-51F5-4329-B957-160E0FAA168EQ36483323-5280B058-5198-4CA3-967C-648A8B375F35Q36553405-3BEA9FE8-AF6D-4FF2-935B-EEE3283DA732Q37115597-2D33B081-2382-4460-BF3C-0C20BB623907Q37642896-7206D53A-3CE9-4EF7-8929-44A8A6A1AB68Q37737972-9DC9DD6C-425A-4584-9523-70D88FAC8119Q38376500-6E8F82B5-9845-4079-94E7-D9013F6652DDQ38651624-C40F7B72-7F52-4548-AC7A-F9A07A6F84DAQ40055950-08A1D4DF-E239-4A64-8DFA-5DB17E5EA9A6Q40432296-82698796-02DD-4A0D-81A4-E29428D82D9DQ41622508-DDA0F1E7-FE99-4D56-993D-84AE0DE8B263Q46252452-7A4494AB-BB75-4ADF-A4E0-02C6FEFB0EF7Q46926980-24ADB4A6-7A6E-40EC-90D9-BB80DF027C0AQ47133377-98F27E7D-8132-4DCF-BB73-C6536D137005Q47550765-8700076E-7728-4662-8804-A69BA528985CQ54238056-BE6018D3-49FD-4D98-9444-B5D773FCA1F1Q54242480-4DFCBC8C-50D7-4179-A0CA-87300E8845A0Q55234148-0E6919D2-12A5-4364-A1EB-4C6619DD8BEBQ56359213-1BF5C805-4790-4826-83CD-FFBD2625F17EQ56362064-09088238-B845-4918-B099-D61874B38FF6
P2860
Red blood cell polymorphism and susceptibility to Plasmodium vivax.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Red blood cell polymorphism and susceptibility to Plasmodium vivax.
@en
Red blood cell polymorphism and susceptibility to Plasmodium vivax.
@nl
type
label
Red blood cell polymorphism and susceptibility to Plasmodium vivax.
@en
Red blood cell polymorphism and susceptibility to Plasmodium vivax.
@nl
prefLabel
Red blood cell polymorphism and susceptibility to Plasmodium vivax.
@en
Red blood cell polymorphism and susceptibility to Plasmodium vivax.
@nl
P2860
P50
P1476
Red blood cell polymorphism and susceptibility to Plasmodium vivax.
@en
P2093
Rosalind E Howes
P2860
P356
10.1016/B978-0-12-407826-0.00002-3
P577
2013-01-01T00:00:00Z